Cargando…
International consensus on radiotherapy in metastatic non-small cell lung cancer
BACKGROUND: Lung cancer is the leading cause of cancer-related death worldwide, with non-small cell lung cancer (NSCLC) accounting for most cases. While radiotherapy has historically served as a palliative modality in metastatic NSCLC, considerable advances in its technology and the continuous devel...
Autores principales: | Zhu, Zhengfei, Ni, Jianjiao, Cai, Xuwei, Su, Shengfa, Zhuang, Hongqing, Yang, Zhenzhou, Chen, Ming, Ma, Shenglin, Xie, Conghua, Xu, Yaping, Li, Jiancheng, Ge, Hong, Liu, Anwen, Zhao, Lujun, Rao, Chuangzhou, Xie, Congying, Bi, Nan, Hui, Zhouguang, Zhu, Guangying, Yuan, Zhiyong, Wang, Jun, Zhao, Lina, Zhou, Wei, Rim, Chai Hong, Navarro-Martin, Arturo, Vanneste, Ben G. L., Ruysscher, Dirk De, Choi, J. Isabelle, Jassem, Jacek, Chang, Joe Y., Kepka, Lucyna, Käsmann, Lukas, Milano, Michael T., Van Houtte, Paul, Suwinski, Rafal, Traverso, Alberto, Doi, Hiroshi, Suh, Yang-Gun, Noël, Georges, Tomita, Natsuo, Kowalchuk, Roman O., Sio, Terence T., Li, Baosheng, Lu, Bing, Fu, Xiaolong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554677/ https://www.ncbi.nlm.nih.gov/pubmed/36248338 http://dx.doi.org/10.21037/tlcr-22-644 |
Ejemplares similares
-
Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses
por: Ni, Jianjiao, et al.
Publicado: (2019) -
Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer
por: Chu, Xiao, et al.
Publicado: (2019) -
Radiographic Features of Metastatic Brain Tumors from ALK-rearranged Non-small Cell Lung Cancer: Implications for Optimal Treatment Modalities
por: Chu, Li, et al.
Publicado: (2019) -
The value of local consolidative therapy in Osimertinib-treated non-small cell lung cancer with oligo-residual disease
por: Zeng, Ya, et al.
Publicado: (2020) -
A narrative review of synergistic drug administration in unresectable locally advanced non-small cell lung cancer: current landscape and future prospects in the era of immunotherapy
por: Li, Shuyan, et al.
Publicado: (2020)